Last reviewed · How we verify
Solid malignant tumours
Approved treatments
- Mozobil · Sanofi
Mozobil works by binding to the C-C chemokine receptor type 2, which helps to mobilize hematopoietic stem cells from the bone marrow into the bloodstream. - Mozobil · University of Washington
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Solid malignant tumours patent landscape — cliff calendar, originator estates, attackable patents
- Solid malignant tumours treatment landscape brief
- Solid malignant tumours treatment updates RSS
Frequently asked questions about Solid malignant tumours
What drugs treat Solid malignant tumours?
Tracked treatments include Mozobil.
What is the treatment for Solid malignant tumours?
Standard treatment for Solid malignant tumours includes Mozobil. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Solid malignant tumours patent cliff · Solid malignant tumours CI report
- Treatment: Mozobil · Sanofi
- Treatment: Mozobil · University of Washington
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing